drugset
Drugs / extracellular vesicles
last change Dec 2020 re-read 3 minutes ago

extracellular vesicles

also known as EVs

Other / unclassified

Developed for
COVID-19
Investigated by
Royan Institute · Shahid Beheshti University of Medical Sciences · Tehran University of Medical Sciences

Trials 1

today NCT04366063 · Ph 2/3
202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/3 NCT04366063 Apr → Jun 2020 COVID-19 Royan Institute Unknown No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as extracellular vesicles “plus two doses of extracellular vesicles (EVs) on Day 4 and Day 6 intravenously.” NCT04366063 ↗
Known as EVs “plus two doses of extracellular vesicles (EVs) on Day 4 and Day 6 intravenously.” NCT04366063 ↗
Modality Other / unclassified “extracellular vesicles (EVs)” NCT04366063 ↗
Route Intravenous “plus two doses of extracellular vesicles (EVs) on Day 4 and Day 6 intravenously.” NCT04366063 ↗